两种不同分流阀在儿童和成人患者中长期功能性与翻修率的回顾性比较
该回顾性研究分析了2014至2020年间400例首次植入脑室腹腔分流管的患者,比较proGAV与proGAV 2.0两种可调压阀的翻修率、1年翻修率及无翻修生存率。结果显示两组在总翻修率、1年翻修率、无翻修生存率和总生存率上均无显著差异;儿童患者翻修手术更频繁,且proGAV组总翻修数显著高于proGAV 2.0组,但作者认为可能与proGAV组随访时间更长有关,故强调1年翻修率分析。
要点
- 400例首次分流管植入患者中,proGAV组283例,proGAV 2.0组117例,两组总翻修率无显著差异(p=0.8069)。
- 儿童患者翻修手术更频繁(46.6% vs 24.8%;p=0.0093),proGAV组总翻修数显著高于proGAV 2.0组(55.9% vs 27.6%;p=0.0110)。
- 作者强调1年翻修率分析,儿童患者两组1年翻修率无显著差异(40.7% vs 27.6%;p=0.2247)。
核心结论
- 根据所分析的目标变量,除儿童患者终生翻修率外,两种分流阀之间无显著差异。
研究设计与样本
- 回顾性比较研究,纳入2014年至2020年间首次植入分流管的400例患者,比较proGAV与proGAV 2.0两种可调压阀。
主要发现
- 400例患者中女性208例、男性192例,99例接受翻修手术;proGAV组283例,proGAV 2.0组117例。
- 两组总翻修率无显著差异(p=0.8069),1年翻修率无显著差异(p=0.9077),无翻修生存率无显著差异(p=0.6921),总生存率无显著差异(p=0.3232)。
- 儿童患者1年翻修率两组无显著差异(40.7% vs 27.6%;p=0.2247)。
- 儿童患者翻修手术更频繁(46.6% vs 24.8%;p=0.0093),proGAV组总翻修数显著高于proGAV 2.0组(33/59例[55.9%] vs 8/29例[27.6%];p=0.0110),作者认为最可能是由于proGAV组随访时间更长。
局限性
- 作者指出proGAV组随访时间更长,可能影响终生翻修率的比较,故强调分析1年翻修率。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The most frequent therapy of hydrocephalus is implantation of ventriculoperitoneal shunts for diverting cerebrospinal into the peritoneal cavity. We compared two adjustable valves, proGAV and proGAV 2.0, for complications resulting in revision surgery. METHODS: Four hundred patients undergoing primary shunt implantation between 2014 and 2020 were analyzed for overall revision rate, 1-year revision rate, and revision-free survival observing patient age, sex, etiology of hydrocephalus, implantation site, prior diversion of cerebrospinal fluid, and cause of revision. RESULTS: All data were available of all 400 patients (female/male 208/192). Overall, 99 patients underwent revision surgery after primary implantation. proGAV valve was implanted in 283 patients, and proGAV 2.0 valves were implanted in 117 patients. There was no significant difference between the two shunt valves concerning revision rate (p = 0.8069), 1-year revision rate (p = 0.9077), revision-free survival (p = 0.6921), and overall survival (p = 0.3232). Regarding 1-year revision rate, we observed no significant difference between the two shunt valves in pediatric patients (40.7% vs 27.6%; p = 0.2247). Revision operation had to be performed more frequently in pediatric patients (46.6% vs 24.8%; p = 0.0093) with a significant higher number of total revisions with proGAV than proGAV 2.0 (33 of 59 implanted shunts [55.9%] vs. 8 of 29 implanted shunts [27.6%]; p = 0.0110) most likely due to longer follow-up in the proGAV-group. For this reason, we clearly put emphasis on analyzing results regarding 1-year revision rate. CONCLUSION: According to the target variables we analyzed, aside from lifetime revision rate in pediatric patients, there is no significant difference between the two shunt valves.
引用
- Busse LC, Dubinski D, Gessler F, et al. Retrospective comparison of long-term functionality and revision rate of two different shunt valves in pediatric and adult patients. Acta Neurochir (Wien). 2023. PMID: 37528210. doi:10.1007/s00701-023-05719-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。